...
首页> 外文期刊>International Journal of Clinical and Experimental Medicine >Meta-analysis of peritumoural rCBV values derived from dynamic susceptibility contrast imaging in differentiating high-grade gliomas from intracranial metastases
【24h】

Meta-analysis of peritumoural rCBV values derived from dynamic susceptibility contrast imaging in differentiating high-grade gliomas from intracranial metastases

机译:动态敏感性对比成像在肿瘤周围rCBV值的荟萃分析,以区分高级别神经胶质瘤与颅内转移瘤

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background and purpose: In the preoperative period, it is very important to accurately differentiate high-grade gliomas from intracranial metastases, as treatment strategies vary. Hence we performed a meta-analysis to evaluate the sensitivity and specificity of peritumoural relative cerebral blood volume (rCBV) values derived from dynamic susceptibility contrast imaging (DSCI) in differentiating high-grade gliomas from intracranial metastases. Materials and methods: Between 2004 and June 2014, relevant studies were searched from the databases of Medline and Embase for analysis. A total of 3 eligible studies were included in this analysis. Statistical analysis was performed with Meta-Disc 1.4. Results: A total of 136 patients included in the rCBV analysis: 79 with high-grade glioma and 57 with metastasis. The pooled sensitivity, specificity, positive likelihood ratio (+LR), negative likelihood ratio (-LR) and diagnostic odds ratio (DOR) for differentiating high-grade glioma from metastasis were 82% (95% CI 0.72-0.90), 96% (95% CI 0.88-1.00), 18.04 (95% CI 5.41-60.15), 0.19 (95% CI 0.12-0.31), and 90.20 (95% CI 23.10-352.27), respectively. The value of Cochran’s Q of DOR was 0.78 (P = 0.6774), and I2 was 0.0%, revealing that no statistically significant between-study heterogeneity was found. Conclusions: The results of this present study clearly present that the peritumoural rCBV values derived from DSCI could be used in distinguishing high-grade gliomas from intracranial metastases in the preoperative.
机译:背景与目的:在术前,随着治疗策略的变化,准确区分高级别神经胶质瘤与颅内转移瘤非常重要。因此,我们进行了荟萃分析,以评估从动态敏感性对比成像(DSCI)得出的肿瘤周围相对脑血容量(rCBV)值在区分高级别神经胶质瘤与颅内转移瘤中的敏感性和特异性。材料和方法:2004年至2014年6月,从Medline和Embase数据库中检索了相关研究以进行分析。该分析总共包括3项合格研究。使用Meta-Disc 1.4进行统计分析。结果:总共136例患者被纳入了rCBV分析:79例为高度胶质瘤,57例为转移瘤。区分高级别胶质瘤和转移的敏感性,特异性,阳性似然比(+ LR),阴性似然比(-LR)和诊断比值比(DOR)分别为82%(95%CI 0.72-0.90),96% (95%CI 0.88-1.00),18.04(95%CI 5.41-60.15),0.19(95%CI 0.12-0.31)和90.20(95%CI 23.10-352.27)。 Cochran的DOR的Q值为0.78(P = 0.6774),I2为0.0%,表明未发现研究之间的异质性。结论:本研究的结果清楚地表明,DSCI得出的肿瘤周围rCBV值可用于区分术前颅内转移灶和高级别神经胶质瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号